Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Cellular and Molecular Life Sciences : CMLS
|
April 6, 2001
Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry
A A Alaiya, M Oppermann, J Langridge, et al.
Urologic Oncology
|
February 21, 2017
Prostate cancer screening in men aged 50 to 69 years (STHLM3): A prospective population-based diagnostic study. Grönberg H, Adolfsson J, Aly M, Nordström T, Wiklund P, Brandberg Y, Thompson J, Wiklund F, Lindberg J, Clements M, Egevad L, Eklund M.Lancet Oncol. 2015 Dec;16(16):1667-76. [Epub 2015 Nov 10]. doi: 10.1016/S1470-2045(15)00361-7
Eggener Scott, J Adolfsson, M Aly, et al.
Cell Death & Disease
|
January 27, 2012
Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells
P Kharaziha, P Rodriguez, Q Li, et al.
Cancer Causes & Control : CCC
|
June 2, 2010
Impact of PSA testing and prostatic biopsy on cancer incidence and mortality: comparative study between the Republic of Ireland and Northern Ireland
A-E Carsin, F J Drummond, A Black, et al.
Pathology
|
September 2, 2015
Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data
B Delahunt, L Egevad, J R Srigley, et al.
British Journal of Cancer
|
July 29, 2004
A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer
M Pavlenko, A-K Roos, A Lundqvist, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 31, 2010
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease
Cristina Magi-Galluzzi, Andrew J Evans, Brett Delahunt, et al.
The Journal of Urology
|
October 25, 2021
Findings in 1,123 Men with Preoperative <sup>68</sup>Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography and Multiparametric Magnetic Resonance Imaging Compared to Totally Embedded Radical Prostatectomy Histopathology: Implications for the Diagnosis and Management of Prostate Cancer
S Raveenthiran, W J Yaxley, T Franklin, et al.
Pathology
|
December 27, 2021
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial
B Delahunt, A Steigler, C Atkinson, et al.
Oncogene
|
November 19, 2013
N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype
H C Whitaker, L L Shiong, J D Kay, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Cellular and Molecular Life Sciences : CMLS
|
April 6, 2001
Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry
A A Alaiya, M Oppermann, J Langridge, et al.
Urologic Oncology
|
February 21, 2017
Prostate cancer screening in men aged 50 to 69 years (STHLM3): A prospective population-based diagnostic study. Grönberg H, Adolfsson J, Aly M, Nordström T, Wiklund P, Brandberg Y, Thompson J, Wiklund F, Lindberg J, Clements M, Egevad L, Eklund M.Lancet Oncol. 2015 Dec;16(16):1667-76. [Epub 2015 Nov 10]. doi: 10.1016/S1470-2045(15)00361-7
Eggener Scott, J Adolfsson, M Aly, et al.
Cell Death & Disease
|
January 27, 2012
Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells
P Kharaziha, P Rodriguez, Q Li, et al.
Cancer Causes & Control : CCC
|
June 2, 2010
Impact of PSA testing and prostatic biopsy on cancer incidence and mortality: comparative study between the Republic of Ireland and Northern Ireland
A-E Carsin, F J Drummond, A Black, et al.
Pathology
|
September 2, 2015
Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data
B Delahunt, L Egevad, J R Srigley, et al.
British Journal of Cancer
|
July 29, 2004
A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer
M Pavlenko, A-K Roos, A Lundqvist, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 31, 2010
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease
Cristina Magi-Galluzzi, Andrew J Evans, Brett Delahunt, et al.
The Journal of Urology
|
October 25, 2021
Findings in 1,123 Men with Preoperative <sup>68</sup>Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography and Multiparametric Magnetic Resonance Imaging Compared to Totally Embedded Radical Prostatectomy Histopathology: Implications for the Diagnosis and Management of Prostate Cancer
S Raveenthiran, W J Yaxley, T Franklin, et al.
Pathology
|
December 27, 2021
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial
B Delahunt, A Steigler, C Atkinson, et al.
Oncogene
|
November 19, 2013
N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype
H C Whitaker, L L Shiong, J D Kay, et al.
Page
of 6